Rhenman & Partners Asset Management’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $4.22M | Sell |
|
|||||
|
2022
Q1 | $5.36M | Sell |
|
|||||
|
2021
Q4 | $5.38M | Hold |
|
|||||
|
2021
Q3 | $8.55M | Hold |
|
|||||
|
2021
Q2 | $12M | Hold |
|
|||||
|
2021
Q1 | $13.4M | Sell |
|
|||||
|
2020
Q4 | $11.5M | Hold |
|
|||||
|
2020
Q3 | $10M | Buy |
|
|||||
|
2020
Q2 | $8.71M | Sell |
|
|||||
|
2020
Q1 | $9.72M | Buy |
|
|||||
|
2019
Q4 | $16.9M | Buy |
|
|||||
|
2019
Q3 | $9.13M | Buy |
|
|||||
|
2019
Q2 | $7.68M | Hold |
|
|||||
|
2019
Q1 | $12.3M | Sell |
|
|||||
|
2018
Q4 | $10.1M | Buy |
|
|||||
|
2018
Q3 | $11.1M | Buy |
|
|||||
|
2018
Q2 | $4.73M | Buy |
|
|||||
|
2018
Q1 | $2.17M | Sell |
|
|||||
|
2017
Q4 | $7.58M | Buy |
|
|||||
|
2017
Q3 | $5.88M | Buy |
|
|||||
|
2017
Q2 | $3.94M | Sell |
|
|||||
|
2017
Q1 | $3.85M | Buy |
|
|||||
|
2016
Q4 | $1.32M | Buy |
|